Novartis Agrees to $175M Gender Bias Settlement

July 15, 2010 (PLANSPONSOR.com) – Novartis Pharmaceuticals Corp. has agreed to settle the remainder of gender bias claims brought by women field representatives for $175 million, according to a New York Law Journal report. 

The Law Journal said $152.5 million will go to a class of plaintiffs of current or former female sales representatives with about $60 million to cover back pay claims.   An additional $22.5 million will go to company programs designed to battle discrimination. 

A federal court jury in New York found for the plaintiffs on May 17 and awarded $3.4 million in damages – a sum that will come out of the settlement money, the Law Journal explained (see Jury Finds Gender Discrimination at Novartis).  The same jury awarded $250 million in punitive damages which the settlement replaces. 

For more stories like this, sign up for the PLANSPONSOR NEWSDash daily newsletter.

The plaintiffs claimed they were discriminated against in pay, promotion, and pregnancy policies.  

«